![](https://cdn.koreabiomed.com/news/thumbnail/202408/24823_25802_5359_v150.jpg)
EN Cell vows to provide multi-product, one-stop service at pre-IPO briefing
En Cell CEO Chang Jong-wook speaks at a news conference on Tuesday held ahead of the company’s IPO. "EN Cell has a track record of multi-product cell and gene therapy (CGT) contract development manufacturing organization (CDMO) with world-class GMP …